Delivery Order SPE2DB22D2206-SPE2DB25FJA67
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,403.32 to AmerisourceBergen Drug Corp for the supply of Mekinist 0.5 mg tablets (30-count units). The contract, awarded July 21, 2025, carries a firm fixed price and is scheduled for completion by August 11, 2025. This is a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global...
- This is a $16,564.61 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the medication Mekinist 2 mg tablet. The award is not set aside and is part of AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which enables the company to supply a wide range of pharmaceutical products and medical supplies to support military and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mekinist 2 mg tablets. The $8,878.79 firm-fixed price contract has an ultimate completion date of October 28, 2024. It does not have a set-aside designation. This order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,670.51, is for the delivery of Mekinist 2 mg tablets, a prescription medication. The delivery order has a firm fixed price and an ultimate completion date of May 23, 2025. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $22,937 firm fixed-price delivery order is for the supply of the prescription medication Mekinist 2 mg tablets. The contract has an ultimate completion date of November 25, 2024 and is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,670.51, is for the delivery of the drug Mekinist 2 mg Tablet and is a firm fixed-price delivery order. The contract has an ultimate completion date of March 28, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $8,878.79 firm fixed-price delivery order is for the supply of the cancer medication Mekinist 2 mg tablets. The award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $5,179.40, is for the delivery of the pharmaceutical product Mekinist 0.5 mg Tablet. This is a firm fixed-price delivery order contract, with a completion date of July 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The $18,371.32 fixed-price award is for the delivery of 4,566,462,969 units of the drug MEKINIST 2 MG Tablet with a completion date of December 10, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the award is...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,623.89 firm fixed-price contract is for the supply of MEKINIST 2 MG TABLET UU 30S, a medical product used in the treatment of various conditions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJA67Delivery Order
The Defense Logistics Agency awarded a $8.55K delivery order to AmerisourceBergen Drug Corp for Mekinist 0.5 mg tablets (30-count units) under a firm fixed price contract. This non-set-aside competitive award was issued on July 23, 2025, with an ultimate completion date of August 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Mekinist is a targeted cancer therapy medication, reflecting the breadth of pharmaceutical products procured through federal medical supply channels. This delivery order represents one of numerous contract awards AmerisourceBergen Drug Corp has received through the Defense Logistics Agency's Medical Supply Chain, with the company serving as a critical vendor for military and veteran healthcare systems. The award is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which provides comprehensive global pharmaceutical support across multiple therapeutic domains. AmerisourceBergen Drug Corp's consistent receipt of competitively awarded delivery orders with firm fixed pricing demonstrates its capability to meet federal medical procurement requirements across various product categories and transaction sizes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 7/23/25 |